A citation-based method for searching scientific literature

Iannis Aifantis, Elizabeth Raetz, Silvia Buonamici. Nat Rev Immunol 2008
Times Cited: 302



John M Goldberg, Lewis B Silverman, Donna E Levy, Virginia Kimball Dalton, Richard D Gelber, Leslie Lehmann, Harvey J Cohen, Stephen E Sallan, Barbara L Asselin. J Clin Oncol 2003
Times Cited: 229




List of shared articles



Times cited

Analysis of the Expression of the TRBC1 in T lymphocyte tumors.
Man Chen, Aixian Wang, Shuqiang Liu, Xueying Wu, Meiwei Gong, Junyi Zhen, Minjing Fu, Hui Wang. Indian J Hematol Blood Transfus 2021
1

G1 Cell Cycle Arrest and Extrinsic Apoptotic Mechanisms Underlying the Anti-Leukemic Activity of CDK7 Inhibitor BS-181.
Shin Young Park, Ki Yun Kim, Do Youn Jun, Su-Kyeong Hwang, Young Ho Kim. Cancers (Basel) 2020
7

Targeting steroid resistance in T-cell acute lymphoblastic leukemia.
Renate De Smedt, Julie Morscio, Steven Goossens, Pieter Van Vlierberghe. Blood Rev 2019
17

T-cell acute lymphoblastic leukemia in infants has distinct genetic and epigenetic features compared to childhood cases.
Mareike Doerrenberg, Andreas Kloetgen, Kebria Hezaveh, Wilhelm Wössmann, Kirsten Bleckmann, Martin Stanulla, Martin Schrappe, Alice C McHardy, Arndt Borkhardt, Jessica I Hoell. Genes Chromosomes Cancer 2017
12

Anti-leukaemic activity of the TYK2 selective inhibitor NDI-031301 in T-cell acute lymphoblastic leukaemia.
Koshi Akahane, Zhaodong Li, Julia Etchin, Alla Berezovskaya, Evisa Gjini, Craig E Masse, Wenyan Miao, Jennifer Rocnik, Rosana Kapeller, Jeremy R Greenwood,[...]. Br J Haematol 2017
21

HSP90 inhibition leads to degradation of the TYK2 kinase and apoptotic cell death in T-cell acute lymphoblastic leukemia.
K Akahane, T Sanda, M R Mansour, T Radimerski, D J DeAngelo, D M Weinstock, A T Look. Leukemia 2016
32